Author

R. Jasuja

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Assay:bulk RNA-seq· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

D. Goldfarb· 2 shared J. E. Eschbach· 2 shared M. B. Major· 2 shared M. Puray-Chavez· 2 shared S. B. Kutluay· 2 shared S. L. Brody· 2 shared A. Horani· 1 shared A. L. Bailey· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

D. Goldfarb

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A basally active cGAS-STING pathway limits SARS-CoV-2 replication in a subset of ACE2 positive airway cell models

M. Puray-Chavez, J. E. Eschbach, M. Xia, K. LaPak, Q. Zhou, R. Jasuja, J. Pan, J. Xu, Z. Zhou, S. Mohammed, Q. Wang, D. Lawson, S. Djokic, G. Hou, S. Ding, , S. B. Kutluay

This study identifies tonic activation of the cGAS-STING and IFN pathways in ACE2-positive airway cells as a factor limiting SARS-CoV-2 replication.

bioRxiv · Jan 7, 2024Microbiology

Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell

M. Puray-Chavez, K. M. Lapak, T. P. Schrank, J. L. Elliott, D. P. Bhatt, M. J. Agajanian, R. Jasuja, D. Q. Lawson, K. Davis, P. W. Rothlauf, H. Jo, N. Lee, K. Tenneti, J. E. Eschbach, C. Shema Mugisha, , S. B. Kutluay

This study identifies H522 cells as ACE2-negative human cells permissive to SARS-CoV-2 infection, revealing alternative receptor usage and host response mechanisms.

bioRxiv · Mar 1, 2021Microbiology

Induction of SARS-CoV-2 protein S-specific CD8+ T cells in the lungs of gp96-Ig-S vaccinated mice

E. Fisher, L. Padula, K. Podack, K. O'Neill, M. M. Seavey, P. Jayaraman, R. Jasuja, N. Strbo

This study shows that the gp96-Ig-S vaccine induces SARS-CoV-2 protein S-specific CD8+ T cells in mice, suggesting potential for human application.

bioRxiv · Aug 24, 2020Immunology